Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-013967
Filing Date
2025-04-15
Accepted
2025-04-15 16:30:32
Documents
22
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20042262x771_def14a.htm   iXBRL DEF 14A 1207254
6 logo_admabiologicsnew.jpg GRAPHIC 38654
7 ny20042262x771_pc01.jpg GRAPHIC 630144
8 ny20042262x771_pc02.jpg GRAPHIC 490493
9 ny20042262x771_pvpchart2.jpg GRAPHIC 180254
10 sig_adamgrossmannew.jpg GRAPHIC 9531
11 ny20042262x771_pvpchartx1.jpg GRAPHIC 219998
  Complete submission text file 0001140361-25-013967.txt   6587431

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA adma-20250604.xsd EX-101.SCH 3251
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE adma-20250604_def.xml EX-101.DEF 3224
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE adma-20250604_lab.xml EX-101.LAB 2339
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE adma-20250604_pre.xml EX-101.PRE 4679
24 EXTRACTED XBRL INSTANCE DOCUMENT ny20042262x771_def14a_htm.xml XML 513006
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36728 | Film No.: 25839953
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)